Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinacrine in Cutaneous Lupus Erythematosus
NCT07694336Phase 2Recruiting
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of quinacrine in cutaneous lupus erythematosus (CLE). Started Jun 2026; status: recruiting.
02
Drugs
quinacrine
03
Conditions
cutaneous lupus erythematosus (CLE)
Beyond the preview
Go deeper on NCT07694336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07694336.